A steady progress in understanding of protein kinase mechanisms has fueled a considerable effort to discover and design selective ATP-competitive and allosteric inhibitors targeting specific forms of cancer, kinase cancer mutants and associated targeted pathways [114]-[116]. Here, WEE1 is linked to cancer.